Bivalirudin in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction (HORIZONS-AMI) (10/2009)
FAME follow-up confirms FFR-guided PCI benefits (10/2009)
PLATO-Invasive confirms ticagrelor benefits (10/2009)
Radiofrequency ablation superior to drugs alone for atrial fibrillation (10/2009)
Timing of intervention in NSTE-ACS (10/2009)
Rapid revascularization supported in left main disease (10/2009)
Influenza–myocardial infarction link confirmed (10/2009)
Comparative amiodarone, dronedarone benefits in AF remain uncertain (10/2009)
Blocking novel phosphodiesterase pathway can prevent cardiac hypertrophy (10/2009)
Post- AMI statin use lowers subsequent HF hospitalization risk (23/9/2008)
Novel oral FXa shows initial anticoagulation promise (22/9/2008)
Triple antithrombotic regimen questioned for AF stent patients (12/9/2008)
Rhabdomyolysis warning for simvastatin and amiodarone treatment (14/8/2008)
Link between positive remodeling and unstable lesions confirmed (1/8/2008)
Aldosterone synthase variant predisposes HF patients to AF (29/7/2008)
Prehypertension in young adulthood linked to coronary artery disease marker later in life (17/7/2008)
Potential familial inheritance pattern in lone AF (20/6/2008)
Aliskiren may have renoprotective effects (10/6/2008)
Fondaparinux better than enoxaparin for non- ST ACS patients with renal dysfunction (21/7/2007)
H-FABP is a novel marker for cardiac damage and remodeling (9/7/2007)
Metformin linked to reduced mortality in diabetic patients with HF (7/7/2007)
Obese MI patients have lower mortality than normal weight MI patients (20/6/2007)
Dual renin system blockade gives further BP reductions (27/3/2007)
Levosimendan fails to improve acute HF outcomes (2/3/2007)
